NuCana plc American Depositary Share
Organization details
- Legal name
- NuCana plc American Depositary Share
- Former names
- NuCana BioMed Ltd
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- United Kingdom
- Headquarters city
- Edinburgh
- Headquarters country
- United Kingdom
- Fiscal year end
- December
- Ticker symbol
- NCNA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001709626
Board of directors
-
Andrew Martin Kay · DirectorSince 2026
-
Cyrille Leperlier · DirectorSince 2026
-
Elliott M. Levy · DirectorSince 2026
-
Hugh Griffith · Director · Chief Executive OfficerSince 2026
-
Martin C.b. Mellish · DirectorSince 2026
Chief executives
Board connections
2 of this board's directors also sit on 3 other boards. 2 are in the same sector.
-
Editas Medicine Inc. Same sectorvia Elliott M. Levy
- via Martin C.b. Mellish
-
Spectral AI Inc. Same sectorvia Martin C.b. Mellish
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about NuCana plc American Depositary Share
Who is the CEO of NuCana plc American Depositary Share?
Hugh Griffith has been NuCana plc American Depositary Share's Chief Executive Officer since March 2026.
How many directors are on NuCana plc American Depositary Share's board?
NuCana plc American Depositary Share's board has 5 directors: Andrew Martin Kay, Cyrille Leperlier, Elliott M. Levy, Hugh Griffith and Martin C.b. Mellish.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="nucana-plc-american-depositary-share"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.